BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9648477)

  • 1. [Bisphosphonates: pharmacology and use in the treatment of osteoporosis].
    Kishimoto H
    Nihon Rinsho; 1998 Jun; 56(6):1531-6. PubMed ID: 9648477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bisphosphonate therapy for osteoporosis and bone strength].
    Kishimoto H
    Clin Calcium; 2006 Sep; 16(9):1513-19. PubMed ID: 16951477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of action of the bisphosphonates.
    Fleisch H
    Medicina (B Aires); 1997; 57 Suppl 1():65-75. PubMed ID: 9567358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials with bisphosphonates.
    Lombardi A; Santora AC
    Ann Ital Med Int; 1992; 7(3 Suppl):158S-165S. PubMed ID: 1297394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates: preclinical aspects and use in osteoporosis.
    Fleisch HA
    Ann Med; 1997 Feb; 29(1):55-62. PubMed ID: 9073324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effects of bisphosphonates in involutional osteoporosis.
    Ott SM
    J Bone Miner Res; 1993 Dec; 8 Suppl 2():S597-606. PubMed ID: 8122531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aredia: the once-monthly infusion for the treatment of bone metastases.
    Lipton A
    Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S1-5. PubMed ID: 9801852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate-osteoclasts: changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients.
    Jobke B; Milovanovic P; Amling M; Busse B
    Bone; 2014 Feb; 59():37-43. PubMed ID: 24211427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Etidronate].
    Inui K; Takaoka K
    Nihon Rinsho; 2003 Feb; 61(2):226-30. PubMed ID: 12638212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 6. Use of bisphosphonates in the treatment of osteoporosis.
    Hodsman A; Adachi J; Olszynski W
    CMAJ; 1996 Oct; 155(7):945-8. PubMed ID: 8837544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate therapy.
    Licata AA
    Am J Med Sci; 1997 Jan; 313(1):17-22. PubMed ID: 9001162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates, specific inhibitors of osteoclast function and a class of drugs for osteoporosis therapy.
    Li B; Ling Chau JF; Wang X; Leong WF
    J Cell Biochem; 2011 May; 112(5):1229-42. PubMed ID: 21465521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial.
    Fukunaga M; Kushida K; Kishimoto H; Shiraki M; Taketani Y; Minaguchi H; Inoue T; Morita R; Morii H; Yamamoto K; Ohashi Y; Orimo H;
    Osteoporos Int; 2002 Dec; 13(12):971-9. PubMed ID: 12459940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of bisphosphonates].
    Nakatsuka K
    Nihon Rinsho; 2003 Feb; 61(2):219-25. PubMed ID: 12638211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is new in the treatment of steroid-induced osteoporosis?
    Liu RH; Werth VP
    Semin Cutan Med Surg; 2007 Dec; 26(4):203-9. PubMed ID: 18395668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacology and therapeutic utility of bisphosphonates.
    Lourwood DL
    Pharmacotherapy; 1998; 18(4):779-89. PubMed ID: 9692651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bisphosphonates: the molecular targets and mechanisms of action].
    Wada S; Kamiya S; Ono K
    Clin Calcium; 2005 May; 15(5):819-24. PubMed ID: 15876745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bisphosphonate therapy in osteoporosis. Inhibition of trabecular perforation by aminobisphosphonate].
    Wüster C; Heilmann P
    Fortschr Med; 1997 Oct; 115(29):37-42. PubMed ID: 9445833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Seibel MJ; Naganathan V; Barton I; Grauer A
    J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT.
    Morishige K; Yamamoto T; Sawada K; Ohmichi M; Tasaka K; Murata Y
    Arch Gynecol Obstet; 2003 Jun; 268(2):105-6. PubMed ID: 12768299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.